salmeterol xinafoate/fluticasone propionate (LIPO 102) / Evofem Biosci - LARVOL DELTA

Studies Give Additional Info on Tezepelumab, Dupilumab Biologics for Asthma (AJMC) - "Michael E. Wechsler, MD, MMSc...provided additional detail from 3 trials on tezepelumab, which will be aimed at treating patients with severe asthma, if approved. Results from one of the studies, the phase 3 NAVIGATOR trial looking at efficacy and safety in adults and adolescents, were published last week in The New England Journal of Medicine....Another presentation, given by Leonard B. Bacharier, MD...focused on a pediatric study for dupilumab, which targets IL-4 and IL-13."

Media quote • Asthma